Plasmotrim™ Rectocaps™
Plasmotrim™ Rectocaps™ is a highly innovative rectal artesunate mono substance for the initial (pre-referral) treatment of severe malaria. Plasmotrim™ Rectocaps™ is the only rectal artesunate available in two dosage strengths with an innovative galenic formulation: Plasmotrim™ Rectocaps™ are thermostable and patent protected.
Plasmotrim™ Rectocaps™ listed on WHO essential drug list for children.
The therapeutic performance of Plasmotrim™ Rectocaps™
Plasmotrim™ Rectocaps™ act very fast and provide rapid fever clearance - Plasmotrim™ Rectocaps™ offer a very rapid symptomatic response. Pre-referral treatment must be supplemented and/or followed by effective oral or parenteral drug therapy as soon as possible.
The tolerability of Plasmotrim™ Rectocaps™
Plasmotrim™ has an excellent overall tolerability and provides a quick stabilization of the patient’s general condition - There are no reports on cases of human embryotoxicity or teratogenicety. Artesunate does not negatively interact with other drugs.